BofA raised the firm’s price target on Procter & Gamble to $171 from $170 and keeps a Buy rating on the shares. The firm made slight tweaks to its model following what it calls a “down the fairway” fiscal Q2 and sees the second half as set for improvement.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target raised to $170 from $161 at UBS
- Procter & Gamble price target raised to $165 from $158 at Wells Fargo
- Procter & Gamble upgraded to Overweight from Neutral at JPMorgan
- Procter & Gamble upgraded to Buy from Hold at DBS Bank
- Procter & Gamble Earnings Call: Growth Abroad, Strains at Home